These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20800617)

  • 1. Transcriptome profiling in neurodegenerative disease.
    Courtney E; Kornfeld S; Janitz K; Janitz M
    J Neurosci Methods; 2010 Nov; 193(2):189-202. PubMed ID: 20800617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw.
    Spires TL; Hannan AJ
    FEBS J; 2005 May; 272(10):2347-61. PubMed ID: 15885086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits.
    Benetti F; Gustincich S; Legname G
    Expert Opin Drug Discov; 2012 Mar; 7(3):245-59. PubMed ID: 22468955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Disease: astrocytes in neurodegenerative disease.
    Maragakis NJ; Rothstein JD
    Nat Clin Pract Neurol; 2006 Dec; 2(12):679-89. PubMed ID: 17117171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics in neurosciences.
    Drabik A; Bierczynska-Krzysik A; Bodzon-Kulakowska A; Suder P; Kotlinska J; Silberring J
    Mass Spectrom Rev; 2007; 26(3):432-50. PubMed ID: 17405153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurodegenerative conformational disease and its molecular bases].
    Li WW; Cai DF; Ren HM
    Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the expression of versican isoforms contribute to the pathogenesis of neurodegenerative diseases?
    Zhang ZW; Zhang JP; Zhou TT; Feng WH; Jiao BH
    Arch Med Res; 2011 Apr; 42(3):258-60. PubMed ID: 21722824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell antisense RNA amplification and microarray analysis as a tool for studying neurological degeneration and restoration.
    Kelz MB; Dent GW; Therianos S; Marciano PG; McIntosh TK; Coleman PD; Eberwine JH
    Sci Aging Knowledge Environ; 2002 Jan; 2002(1):re1. PubMed ID: 14602975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein misfolding in neurodegenerative diseases.
    Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence?
    Thompson A; Boekhoorn K; Van Dam AM; Lucassen PJ
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():28-42. PubMed ID: 18184368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Genomics meets neurodegenerative disorders. Part II: application and data integration.
    Hoerndli F; David DC; Götz J
    Prog Neurobiol; 2005 Jun; 76(3):169-88. PubMed ID: 16169146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes and the environment in neurodegeneration.
    Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
    Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing human post-mortem brain tissue gene expression profiling in Parkinson's disease and other neurodegenerative disorders: from target "fishing" to translational breakthroughs.
    Papapetropoulos S; Shehadeh L; McCorquodale D
    J Neurosci Res; 2007 Nov; 85(14):3013-24. PubMed ID: 17503538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V; Pan TH; LE WD
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer therapy for neurodegenerative disorders.
    Feigin A; Eidelberg D
    Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK; Paul S
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.
    Tan CC; Yu JT; Tan MS; Jiang T; Zhu XC; Tan L
    Neurobiol Aging; 2014 May; 35(5):941-57. PubMed ID: 24360503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.